ICD-10-PCS › X New Technology › X2 Cardiovascular System › X2R New Technology, Cardiovascular... › X2R80WA

X2R80WA

Replacement of Left Lower Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10

ValidICD-10-PCS procedure code.

Valid for claims with a date of service in the current code year.

Valid FY2025 onwards.

What has happened to this code

Every change the publisher made, from 2025 to now.

  1. FY2025 Added to the code set Replacement of Left Lower Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10

What this code says

Each character is read in its own position, so the same letter means different things in different places. Definitions are CMS's own.

3. Root operation Replacement

Putting in or on biological or synthetic material that physically takes the place and/or function of all or a portion of a body part

5. Approach Open

Cutting through the skin or mucous membrane and any other body layers necessary to expose the site of the procedure

Codes in the same group

CodeDescriptionStatus
X2R50WA Replacement of Right Upper Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10 Valid
X2R60WA Replacement of Left Upper Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10 Valid
X2R70WA Replacement of Right Lower Extremity Artery using Bioengineered Human Acellular Vessel, Open Approach, New Technology Group 10 Valid
X2RF032 Replacement of Aortic Valve using Zooplastic Tissue, Rapid Deployment Technique, Open Approach, New Technology Group 2 Retired
X2RF332 Replacement of Aortic Valve using Zooplastic Tissue, Rapid Deployment Technique, Percutaneous Approach, New Technology Group 2 Retired
X2RF3LC Replacement of Aortic Valve using Zooplastic Tissue, with Integrated Native Leaflet Clipping Locators, Percutaneous Approach, New Technology Group 12 Valid
X2RF432 Replacement of Aortic Valve using Zooplastic Tissue, Rapid Deployment Technique, Percutaneous Endoscopic Approach, New Technology Group 2 Retired
X2RG3FC Replacement of Mitral Valve with Balloon-expandable Bioprosthetic Valve with Dock, Percutaneous Approach, New Technology Group 12 Valid
X2RH0GC Replacement of Pulmonary Valve using Size-Adjustable Synthetic Substitute, Open Approach, New Technology Group 12 Valid
X2RJ3RA Replacement of Tricuspid Valve with Multi-plane Flex Technology Bioprosthetic Valve, Percutaneous Approach, New Technology Group 10 Valid
X2RX0N7 Replacement of Thoracic Aorta, Arch using Branched Synthetic Substitute with Intraluminal Device, Open Approach, New Technology Group 7 Valid